Results
3050
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
3050 companies
Panbela Therapeutics
Market Cap: US$242.7k
A clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs.
PBLA
US$0.05
7D
-66.7%
1Y
-85.7%
Allied
Market Cap: US$1.3m
A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.
ALID
US$0.011
7D
0%
1Y
-87.5%
Genomics BioSci & Tech.Ltd
Market Cap: NT$1.8b
Operates as a genomic company in Taiwan.
4195
NT$24.95
7D
1.6%
1Y
37.8%
Guangxi Wuzhou Zhongheng Group
Market Cap: CN¥8.7b
Researches, develops, manufactures, and sells pharmaceuticals in China.
600252
CN¥2.73
7D
1.5%
1Y
45.2%
TiumBio
Market Cap: ₩156.7b
A drug discovery company, researches and develops therapeutics for patients with unaddressed rare diseases.
A321550
₩5,670.00
7D
6.8%
1Y
3.1%
Hubei Goto BiopharmLtd
Market Cap: CN¥2.5b
Engages in the research, development, production, and sale of steroid drug raw materials and intermediates in China and internationally.
300966
CN¥22.15
7D
2.0%
1Y
55.4%
Bioneer
Market Cap: ₩377.6b
Operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally.
A064550
₩14,460.00
7D
0.6%
1Y
-43.1%
Shaanxi Kanghui Pharmaceutical
Market Cap: CN¥2.4b
Engages in the research and development, production, and sale of pharmaceutical products in China.
603139
CN¥23.81
7D
2.9%
1Y
102.1%
Vicapsys Life Sciences
Market Cap: US$57.3m
Focuses on the development and commercialization of VICAPSYN, a proprietary product.
VICP
US$1.77
7D
0%
1Y
-34.9%
ZYUS Life Sciences
Market Cap: CA$50.8m
Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.
ZYUS
CA$0.65
7D
-5.8%
1Y
-30.1%
Greater Cannabis Company
Market Cap: US$270.0k
Engages in the development and commercialization of cannabinoid therapeutics.
GCAN
US$0.0002
7D
0%
1Y
-71.4%
Breeze Holdings Acquisition
Market Cap: US$1.1b
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs.
YDES
US$15.55
7D
13.9%
1Y
38.3%
Rapid Dose Therapeutics
Market Cap: CA$21.3m
A life sciences company, provides drug delivery technologies in Canada.
DOSE
CA$0.16
7D
-5.9%
1Y
14.3%
BeyondSpring
Market Cap: US$78.2m
A clinical stage biopharmaceutical company, focuses on the development of cancer therapies.
BYSI
US$1.94
7D
6.0%
1Y
-7.2%
PreveCeutical Medical
Market Cap: CA$20.0m
A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.
PREV
CA$0.035
7D
0%
1Y
133.3%
Chimin Health Management
Market Cap: CN¥6.6b
Researches, develops, produces, and sells human medicines and medical devices in China and internationally.
603222
CN¥12.78
7D
22.1%
1Y
131.5%
3billion
Market Cap: ₩196.0b
Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.
A394800
₩6,200.00
7D
-0.6%
1Y
n/a
Recce Pharmaceuticals
Market Cap: AU$138.8m
Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti–infectives in Australia, the United Kingdom, and the United States.
RCE
AU$0.44
7D
3.5%
1Y
-13.7%
HanchorBio
Market Cap: NT$9.5b
Operates as a biotechnology company that develops biologics for cancer patients.
7827
NT$78.00
7D
1.3%
1Y
n/a
Hangzhou Bio-Sincerity Pharma-TechLtd
Market Cap: CN¥6.7b
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
301096
CN¥61.46
7D
-2.2%
1Y
72.5%
LabGenomics
Market Cap: ₩168.5b
Engages in the research and development of biotechnology products in South Korea.
A084650
₩2,310.00
7D
3.8%
1Y
-22.0%
ABION
Market Cap: ₩150.2b
Operates as a pharmaceutical biotech Company in South Korea and internationally.
A203400
₩5,130.00
7D
-6.9%
1Y
-34.2%
IT-ChemLtd
Market Cap: ₩221.7b
IT-CHEM Co., Ltd. develops and manufactures materials for the pharmaceutical and display markets.
A309710
₩17,860.00
7D
-10.2%
1Y
n/a
JS Link
Market Cap: ₩501.2b
A genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.
A127120
₩17,560.00
7D
-0.7%
1Y
475.7%
Ecofibre
Market Cap: US$366.6k
Engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia.
EOFB.F
US$0.001
7D
0%
1Y
-93.3%
Filament Health
Market Cap: US$5.2m
Operates as a clinical-stage natural psychedelic drug development company in Canada.
FLHL.F
US$0.02
7D
0%
1Y
-50.0%
Cresanto Global
Market Cap: ₹15.6m
Does not have significant operations.
531207
₹3.65
7D
0%
1Y
39.3%
Genomtec
Market Cap: zł91.3m
Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.
GMT
zł6.14
7D
-2.8%
1Y
-25.0%
America Great Health
Market Cap: US$12.7m
Operates as a biotechnology company in the United States.
AAGH
US$0.0006
7D
-14.3%
1Y
-78.6%
BioNTech
Market Cap: US$24.5b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
BNTX
US$102.09
7D
1.5%
1Y
1.5%
NovelStem International
Market Cap: US$843.9k
A development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy.
NSTM
US$0.018
7D
0%
1Y
n/a
Tempus AI
Market Cap: US$14.1b
Operates as a healthcare technology company.
TEM
US$81.01
7D
3.4%
1Y
79.8%
Manhattan Scientifics
Market Cap: US$559.0
A technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States.
MHTX
US$0.000001
7D
0%
1Y
-99.9%
CNBX Pharmaceuticals
Market Cap: US$221.6k
A clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer.
CNBX
US$0.0004
7D
-20.0%
1Y
-94.3%
NAVCO Pharmaceuticals
Market Cap: CA$285.3k
Develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada.
NAV
CA$0.005
7D
0%
1Y
-90.9%
SK bioscienceLtd
Market Cap: ₩3.8t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩48,750.00
7D
-0.8%
1Y
-8.9%